Washington: Pfizer Inc. on Tuesday announced it is seeking Emergency Use Authorization (EUA) of its investigational oral antiviral candidate, PAXLOVID, for the treatment of mild to moderate COVID-19 in patients at increased risk of hospitalizations or death. more
Pfizer could have first oral drug for COVID-19 by end of year: CEO Bourla

Washington/Sputnik: Pfizer’s experimental oral drug to treat COVID-19 at the first sign of illness could be available before the end of the year, Chief Executive Albert Bourla told ...